Gold prices steady ahead of Fed decision; weekly weakness noted
DEERFIELD, Ill. & SAN FRANCISCO - Walgreens and KFF’s Greater Than HIV/STDs campaign will offer free rapid HIV, syphilis and hepatitis C testing at more than 575 Walgreens stores on June 27 for National HIV Testing Day.
The initiative involves over 415 local health departments and community organizations across nearly all states, Washington, D.C., and Puerto Rico, marking the largest participation in the partnership’s 15-year history. Since 2011, the collaboration has provided more than 93,000 free HIV/STD tests. With investors’ attention on healthcare initiatives, InvestingPro subscribers can access exclusive insights and detailed analysis through the comprehensive Pro Research Report, available for Walgreens and 1,400+ other top stocks.
"This year’s record-breaking National HIV Testing Day activation shows the power of public-private partnership," said Tina Hoff, KFF Senior Vice President.
Testing will be conducted in private areas of stores or mobile units by trained counselors, with results available within 20 minutes. Information about prevention methods, including PrEP and doxy-PEP, will also be provided.
The expanded testing offerings come amid ongoing high rates of syphilis and other STDs in the U.S. Leading manufacturers have donated more than 22,000 rapid test kits to support the event.
Rick Gates, chief pharmacy officer at Walgreens, noted that all Walgreens pharmacists receive HIV prevention training, with approximately 3,000 specialty and community pharmacists completing advanced training in HIV treatment and prevention.
The initiative is further supported by national health organizations including the Association of State and Territorial Health Officials and the National Association of County and City Health Officials.
Walgreens (NASDAQ:WBA) operates approximately 8,500 stores throughout the U.S. and Puerto Rico, offering investors an attractive 8.82% dividend yield. The company is scheduled to report its next earnings on June 26, which InvestingPro subscribers can analyze using advanced financial metrics and expert insights. The information in this article is based on a press release statement.
In other recent news, Walgreens Boots Alliance, Inc. has made significant financial and legal moves. The company has terminated two major credit agreements and launched a new accounts receivable securitization facility with a capacity of up to $2.5 billion. This new facility was created to repay existing debts under previous term loan agreements with Bank of America and Toronto Dominion. Additionally, Walgreens has settled a major legal dispute with the Department of Justice concerning allegations related to opioid dispensing. The settlement involves a payment of $300 million plus interest over six years, with an initial payment of $20 million due soon. As part of the agreement, Walgreens does not admit wrongdoing, and all claims against the company and the DEA will be dismissed. These developments mark the resolution of significant financial and legal challenges for Walgreens.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.